Cardiovascular and Pulmonary Challenges After Treatment of Childhood Cancer.
Options
BORIS DOI
Publisher DOI
PubMed ID
33131539
Description
Childhood cancer survivors are at risk for developing cardiovascular disease and pulmonary disease related to cancer treatment. This might not become apparent until many years after treatment and varies from subclinical to life-threatening disease. Important causes are anthracyclines and radiotherapy involving heart, head, or neck for cardiovascular disease, and bleomycin, busulfan, nitrosoureas, radiation to the chest, and lung or chest surgery for pulmonary disease. Most effects are dose dependent, but genetic risk factors have been discovered. Treatment options are limited. Prevention and regular screening are crucial. Survivors should be encouraged to adopt a healthy lifestyle, and modifiable risk factors should be addressed.
Date of Publication
2020-12
Publication Type
Article
Keyword(s)
Cardiovascular Childhood cancer survivor Late effects Pulmonary
Language(s)
en
Contributor(s)
Visscher, Henk | |
Feijen, E A M Lieke | |
Nathan, Paul C |
Additional Credits
Series
Pediatric clinics of North America
Publisher
Elsevier
ISSN
1557-8240
Access(Rights)
open.access